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of neonatal group B streptococcal infection
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Group B streptococcal (GBS) meningitis remains a devastating disease. The absence of an
animal model reproducing the natural infectious process has limited our understanding of
the disease and, consequently, delayed the development of effective treatments. We describe
here a mouse model in which bacteria are transmitted to the offspring from vaginally colo-
nised pregnant females, the natural route of infection. We show that GBS strain BM110,
belonging to the CC17 clonal complex, is more virulent in this vertical transmission model
than the isogenic mutant BM110ΔcylE, which is deprived of hemolysin/cytolysin. Pups
exposed to the more virulent strain exhibit higher mortality rates and lung inflammation than
those exposed to the attenuated strain. Moreover, pups that survive to BM110 infection
present neurological developmental disability, revealed by impaired learning performance
and memory in adulthood. The use of this new mouse model, that reproduces key steps
of GBS infection in newborns, will promote a better understanding of the physiopathology of
GBS-induced meningitis.
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Neonatal bacterial meningitis is a severe life-threateningdisease and a major cause of neurological disabilityworldwide. Group B Streptococcus (GBS) remains the
leading cause of severe invasive infections among neonates and,
together with Escherichia coli, account for at least two-thirds of all
deaths from neonatal meningitis1,2. GBS is a commensal organ-
ism of the genitourinary and/or gastrointestinal tract of adult
humans and has been isolated from vagina and/or rectum of
15–40% of pregnant women2. Maternal colonisation and trans-
mission to foetus and newborns is the most common cause of
neonatal GBS infections leading to pneumonia, septicaemia and
meningitis2.
The current prevention strategy of intrapartum antibiotic
prophylaxis (IAP), for parturient at risk of GBS transmission to
newborns, has reduced the cases of pneumonia and
septicaemia2,3. The incidence rates of GBS meningitis have
remained relatively stable over the past 20 years4,5 but now
appear to be increasing6,7. Furthermore, maternal colonisation is
not affected by IAP treatment3 and the overall mortality rate for
GBS neonatal infections remains at approximately 10%. As a
consequence, morbidity rates associated with meningitis caused
by GBS infection has not changed substantially over decades2,8
remaining unacceptably high. In addition, up to 50% of surviving
infants experience neurodevelopmental impairment (NDI)2,9–11,
highlighting the inefficacy of current treatment and the urgent
need for new preventive and/or therapeutic approaches. The
mechanisms that lead to the devastating outcome of GBS-induced
meningitis are not elucidated. Clinical data concerning neonatal
meningitis are limited as this disease is difficult to diagnose due to
subtle and nonspecific symptoms8,12, and it is estimated that
more than 30% of the cases are asymptomatic13,14. Moreover,
protocols in which only neonates with confirmed bacteraemia are
evaluated for meningitis result in missed diagnoses, as blood
cultures may be negative in 15–38% of cases12. Thus, a better
understanding of the pathogenesis and pathophysiology of GBS
meningitis must be gained. To this end, mice and rat models of
GBS disease have been developed, but they often target a parti-
cular step of the pathophysiological process (organ colonisation,
septicaemia, meningitis) and although they have generated
important knowledge, they also have the potential of yielding
misleading information. This is particularly the case when non-
natural infection routes, such as intraperitoneal, subcutaneous,
or intracerebral GBS inoculation, that by-pass the mother-to-
newborn transmission and the normal bacteraemia-meningitis
sequence in the neonate, are used15–19. Moreover, the use of
irrelevant animal models in research results in a lower likelihood
of translation to the clinic20,21. Thus, an animal model in which
the disease induced closely resembles GBS natural infection in
humans is still missing.
Here, we present a mouse model that recapitulates the GBS
newborn infection pathogenesis by enabling vertical transmission
of the pathogen from vaginally colonised pregnant females to
their progeny. We validate this model by using the hypervirulent
GBS strain BM110, a serotype III strain belonging to the hyper-
virulent clonal complex 17 (CC17)22–24. In addition, the atte-
nuated isogenic mutant BM110ΔcylE that does not express the
pore-forming toxin β-hemolysin/cytolysin (β-h/c) was used. This
toxin is an important virulent factor25–27 whose overexpression
leads to preterm labour in pregnant nonhuman primates28.
Our data show that neonatal mice born from mothers colo-
nised with the hyper-virulent GBS strain exhibit enhanced mor-
tality and lung pathology, which correlates with higher bacterial
load. Importantly, newborns that survive to BM110 infection
experience permanent NDI, as observed in humans. Thus, this
mouse model, which mimics the human pathophysiology of GBS
diseases, should allow a better understanding of the pathophy-
siology of GBS meningitis and open new avenues towards the
identification of new therapeutic and neuroprotective strategies.
Results
β-h/c expression favours colonisation of mouse vagina.
Knowing that human neonates acquire the bacterium by vertical
transmission, pregnant BALB/c mice were inoculated intra-
vaginally (i.vag.) with the serotype III hypervirulent strain CC17
BM110 or the isogenic attenuated strain BM110ΔcylE lacking
haemolytic/cytolytic activities. After several attempts, days 17 and
18 of gestation (G17 and G18) were defined as the specific win-
dow to administer the bacteria (Fig. 1a). Vaginal colonisation was
monitored upon delivery by vaginal lavage and plating of
recovered bacteria (the delivery day was excluded due to excess
of blood and body fluids). At day one after birth, and with both
GBS strains, the vaginal mucosa of all females presented high
bacterial load enabling the vertical transmission of the bacterium
(Fig. 1b,c). Thereafter, the bacterial levels started to decrease, but
more abruptly with BM110ΔcylE mutant than with BM110 WT
(Fig. 1b, c). After day 6 upon delivery, the levels of bacteria
remained almost exclusively below the detection threshold for the
attenuated strain, while a transient and intermittent colonisation
was observed with the hyper-virulent strain. At day 60, no bac-
terium was detected in the vaginal mucosa of all females in either
group (Fig. 1b, c). Data from individual progenitors are depicted
in Supplementary Fig. 1a and b.
β-h/c expression induces a severe pathology to neonatal mice.
As GBS is a major cause of stillbirth, we monitored the foetal
death in pregnant mice colonised either with the hyper-virulent
or the attenuated GBS strain. Stillborn accounted for 14 or 5% of
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Fig. 1 Vaginal GBS colonisation of female mice. a A schematic illustration of the colonisation model is shown. Pregnant BALB/c mice were intra-vaginally
inoculated with 3 × 104 CFU of GBS BM110 WT or BM110ΔcylE at gestational days 17 and 18. b After birth, GBS vaginal colonisation levels were determined
at the indicated time-points in vaginal lavage by enumerating onto selective media GBS colony-forming units (CFU) [mean ± SEM, n= 10 (BM110 WT) and
n= 9 (BM110ΔcylE)]. Comparisons by two-way ANOVA, with Sidak’s multiple comparison. *P < 0.05, **P < 0.01. c The percentage of mice remaining
colonised after birth is shown [n= 10 (BM110 WT) and n= 9 (BM110ΔcylE)]
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all pups born from BM110 or BM110ΔcylE-colonised females,
respectively, while none was observed in non-colonised mothers
(Fig. 2a). Following delivery, approximately 40% of the pups born
from BM110-colonised females died after birth, 21% during the
first 24 h of life, while 12% of pups born from BM110ΔcylE-
colonised mothers died after birth, 6% in the first 24 h (Fig. 2b).
In the non-colonised control group, only 6% of the pups died
during the first 24 h of life (Fig. 2b). No death was recorded after
postnatal day (PND) 4 in all groups of mice (Fig. 2b).
Measurement of weight gain, a sensitive marker of neonatal
well-being, was recorded during the first 10 days of life. Body
weight gain was reduced in pups born from GBS-colonised
progenitors compared to those born from non-colonised mothers
(Fig. 2c, d). This reduction was more pronounced with the pups
from BM110 WT- colonised mothers (8 days) compared to pups
from BM110ΔcylE-colonised mothers (4 days) (Fig. 2c).
As pneumonia frequently heralds early stages of neonatal
GBS disease, we investigated bacterial load and signs of lung
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Fig. 2 GBS vertical transmission. Pregnant BALB/c mice were intra-vaginally inoculated with 3 × 104 CFU of GBS BM110 WT, BM110ΔcylE, or PBS
(uninfected) at gestational days 17 and 18. a Percentage of term stillbirths born from indicated dams. Each symbol indicates data from a single mouse
[mean, n= 15 (uninfected), n= 20 (BM110 WT) and n= 11 (BM110ΔcylE)]. Comparisons by one-way ANOVA, with Sidak’s multiple comparison.
*P < 0.05, **P < 0.01. b Kaplan–Meier survival curve of neonatal mice, monitored for 30 days. Numbers in parentheses represent surviving pups versus
total born [n= 49 (uninfected), n= 94 (BM110 WT) and n= 49 (BM110ΔcylE)]. Comparisons with log-rank (Mantel-Cox) test. **P < 0.01, ***P < 0.001
and n.s., not significant. c Body weight gain of mice following birth [mean ± SEM, n= 22 (uninfected), n= 34 (BM110 WT) and n= 12 (BM110ΔcylE)].
* represents the comparison between BM110 WT and uninfected pups, † BM110ΔcylE and uninfected pups, and ‡ BM110 WT and BM110ΔcylE pups.
Comparisons by two-way ANOVA, with Sidak’s multiple comparison. *,†P < 0.05, ***,†††,‡‡‡P < 0.001 and ****,‡‡‡‡P < 0.0001. d Overall appearance of an
offspring born from uninfected (left), BM110 WT- (middle), or BM110ΔcylE-colonised (right) progenitors at PND7. e, i, j, l, m GBS counts in lungs (e), gut
(i), blood (j), liver (l), and brain (m) in the offspring born from BM110 WT- or BM110ΔcylE-colonised progenitors at different time points after birth.
Each symbol indicates data from single pups [mean, n= 11 (PND1), n= 21 (PND2 and 7), n= 9 (PND3), n= 13 (PND15) and n= 13 (PND30) for BM110
WT; n= 8 (PND1), n= 9 (PND2 and 7), n= 15 (PND3), n= 6 (PND15 and 30) for BM110ΔcylE]. Comparisons by two-way ANOVA, with Sidak’s Multiple
comparison. *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001. f–h H&E staining of pulmonary tissue from uninfected (f), BM110 WT- (g), or
BM110ΔcylE- (h) colonised progenitors, at PND1. Representative micrographs are shown. Black arrow indicates interstitial inflammation and areas of
atelectasis. Arrowheads indicate oedema and severe haemorrhage. Red arrow indicates mild atelectasis areas. Scale bar, 100 μm. k, n Percentage
of neonatal mice whose blood (k) and brain (n) contained GBS at the indicated time points
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inflammation, or loss of structure, in pups born from colonised
mothers. Higher and sustained GBS bacterial loads were detected
in the lungs of pups born from BM110 WT-colonised progenitors
compared to those born from BM110ΔcylE-colonised mothers
(Fig. 2e). These bacterial loads were correlated with the observed
lung pathology (Fig. 2f–h). Indeed, neonates born from BM110
WT-colonised mothers displayed significant lung pathology with
the presence of areas of atelectasis lung inflammation with
moderate neutrophil infiltration in the alveoli and interstitium,
narrowed airway lumen, oedema and severe haemorrhage. In
contrast, pups born from BM110ΔcylE-colonised mothers
showed reduced lung inflammation with mild atelectasis and
mild increased thickness of alveolar wall (Fig. 2f–h). Gut GBS
colonisation was also quantified and only at PND1, the pups born
from BM110-colonised mothers presented higher levels of
bacteria than those born from BM110ΔcylE-colonised mothers
(Fig. 2i). Thereafter, no significant differences were observed
between pups born from hyper-virulent or attenuated GBS-
colonised females with both groups presenting high levels of GBS
(Fig. 2i).
As this bacterium can disseminate into the bloodstream, GBS
was also quantified in the blood of pups born from colonised
mothers. GBS were present in the blood of 60% of pups born
from BM110-colonised progenitors, reaching a maximum at
PND1, but were no longer detected at PND7 (Fig. 2j, k). In
contrast, no bacterium was detected in the blood of pups born
from BM110ΔcylE-colonised mothers (Fig. 2j, k). The bacterial
load was also quantified in the liver, an organ playing a key role
during sepsis. As expected, pups born from BM110 WT-colonised
mothers presented higher levels of GBS than those born from
BM110ΔcylE-colonised mothers (Fig. 2l). GBS was also quantified
in the brain of pups and although the blood of neonatal mice
born from mothers colonised with the attenuated strain was
negative for GBS, bacteria were detected in their brains up to
PND15 (Fig. 2m). The level of brain colonisation was always
slightly less than that observed in pups born from BM110 WT-
colonised mothers, but the differences were not significant except
at PND5 (Fig. 2m). The percentage of pups with brain
colonisation at PND5 was 94% (15 out of 16) for those infected
with BM110 and 50% (8 out of 16) for those infected with
BM110ΔcylE (Fig. 2n). This indicates that almost all pups
surviving the infection caused by the hyper-virulent strain have
experienced meningitis.
To confirm that moribund animals infected with BM110 WT
were dying from sepsis-related multiple organ failure, serum levels
of several biochemical parameters were quantified at PND1 in
pups born from BM110-colonised mothers (BM110) and in pups
born from non-colonised mothers (Uninfected). The levels of
aspartate transaminase [AST (U L−1), BM110: 685.0 ± 8.66 and
Uninfected: 32.50 ± 12.99], and creatine kinase [CK (U L−1),
BM110: 7625 ± 4021 and Uninfected: 60.00 ± 23.09] were much
higher in the serum of pups infected with BM110 WT than in the
serum of uninfected pups. These results confirmed liver and heart
failure in the group of infected pups. No significant differences
were observed in the serum levels of creatinine [CREA (µmol L−1),
BM110: 2.50 ± 0.87 and Uninfected: 0.625 ± 0.22] and urea
nitrogen [BUN (mmol L−1), BM110: 16.00 ± 0.577 and Unin-
fected: 17.50 ± 1.44] between the infected and uninfected groups
indicating that the kidneys were functional.
The IAP administration of ampicillin or penicillin to GBS-
colonised pregnant women is routinely used to prevent neonatal
diseases. Therefore, BM110-colonised pregnant mice were
prophylactically treated with ampicillin added to their drinking
water from gestational day 20 (one day before delivery) until
PND1. A significantly increased survival was observed in the
group of pups born from IAP-treated mothers (87% survival), as
compared to those born from untreated progenitors (59%
survival) (Supplementary Fig. 2a). Moreover, at PND5, bacterial
counts in the organs tested were below detection level in almost
all pups born from IAP-treated mother, with only 1 out of 9 pups
displaying gut and brain colonisation (Supplementary Fig. 2b–f).
These results suggest that our mouse model can be used to test
the efficacy of new prophylactic treatments against neonatal GBS
infections.
GBS-induced meningitis in neonates born from colonised
mice. GBS-induced meningitis is often associated with long-term
NDI and epidemiological studies have revealed that it is
caused mainly by strains belonging to the hyper-virulent CC17
lineage22–24. Therefore, we compared at PND5 the brain of pups
born from BM110-colonised mothers (infected pups) with those
born from non-colonised progenitors (uninfected pups). The
brain of infected pups exhibited the hallmarks of meningitis such
as meningeal congestion, vascular hyperaemia, and oedema
(Fig. 3a). Moreover, haemorrhage and hyperaemia were also
found in the choroid plexus located in the dorsal third ventricle of
infected pups (Fig. 3a). No histological alterations were observed
in the brain of infected pups (Fig. 3a, c, e). Immunofluorescence
analysis revealed the presence of GBS within the brain par-
enchyma (Fig. 3b). To investigate blood–brain barrier (BBB)
breakdown, its integrity was evaluated in the pups’ brains at
PND5 by the Evans blue (EB) dye assay. Higher values of vascular
permeability were detected in the brains of infected pups, as
compared to those observed in uninfected pups (Fig. 3c, left). The
EB extravasation was further visualised by fluorescence imaging
using the IVIS Lumina system (Fig. 3c, right). Cortical thickness,
measured as indicated in Fig. 3e, was significantly decreased in
brains from infected pups evidencing higher neuronal density and
poorer discrimination of the different cortical layers (Fig. 3d).
This may result from the observed expansion of lateral ventricles
(Fig. 3d), a likely consequence of GBS ventriculitis29. However,
the thickness of the white matter (corpus callosum) of brains
from infected pups was not modified (Fig. 3e) and regions of
abnormal necrotic death were not observed.
Microglia activation and neuronal apoptosis in infected brain.
To investigate whether brain inflammatory response was present,
cytokines known to be relevant for bacterial meningitis was
quantified in serum and brain of infected and uninfected pups at
PND5. The levels of tumour necrosis factor (TNF)-α, interleukin
(IL)−17 and interferon (IFN)-γ were significantly lower in the
serum of infected pups compared to uninfected pups (Fig. 4a)
whereas the levels of keratinocyte chemoattractant (KC), mac-
rophage inflammatory proteins (MIP)−1α, IL-1β, IL-6 and IL-10
were similar (Fig. 4a). No differences were observed in the levels
these 8 cytokines measured in brains of infected and uninfected
pups (Fig. 4b). To gain insight into the mechanism responsible
for brain damage, we next analysed the leucocytes present at
PND5 in the brain of pups born from BM110-colonised mothers
together with the status of microglia activation. In this analysis, to
distinguish resident from infiltrating myeloid cells, we used a
common classification method based on CD45 expression, which
is higher on infiltrating cells30. Cells were gated on CD45+
immune cells and among CD45low cells (resident cells) those
expressing CD11b+ were identified as resident myeloid cells
(commonly known as microglia), whereas the CD11b+CD45hi
cells were identified as infiltrating myeloid cells (Fig. 4c). We
further gated CD45hiCD11b+ to distinguish between granulo-
cytes (CD11b+Ly6G+) and monocytes/macrophages (CD11b
+Ly6G−) (Fig. 4c). A significant increase in the frequency of
resident myeloid cells was observed in brains from infected pups
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compared with brains from uninfected pups while no significant
difference was detected in the infiltrating myeloid cells population
(Fig. 4d, e). Higher expression of CD11b was observed in the
resident myeloid population of brains from infected pups com-
pared to those from uninfected pups (Fig. 4f). Increased expres-
sion of CD11b levels is associated with resident myeloid cells
activation31, indicating that the microglia of infected pups was
activated. No alterations were detected in the expression levels of
MHC class II and Ly6C in resident myeloid cells (Supplementary
Fig. 3a, b). Although no differences were observed in the levels of
the CD11b+Ly6G+ population between brains from infected and
uninfected pups, the mean fluorescence intensity of CD44 (an
important receptor for cell motility upregulated upon cell acti-
vation) was significantly increased in brains from infected pups
(Fig. 4g), indicating neutrophil activation. A significant decrease
in Ly6Chi inflammatory monocytes involved in brain homo-
eostasis32 was observed in brains from infected compared to those
from uninfected pups (Fig. 4h). Concomitantly, the proportion of
Ly6Cint/low monocytes was increased in brain from infected pups.
Since pathological stimuli affect both microglia functional state
and anatomical structure33, we used Iba1+ staining to visualise
changes in microglia morphology at PND5 in brains from
infected and uninfected pups. At this time-point, microglia is
usually uniform throughout the brain despite the presence of
microglia region-specific phenotypes34. As expanded lateral
ventricles were observed in brains from infected pups, we focused
our attention on the striatum and hippocampus (CA3 region). In
both regions (Fig. 4i), a shift towards an insult-responsive
phenotype was observed in infected pups, characterised by
reduced branching and increased soma size33, which is coherent
with the observed activation state (Fig. 4f).
Astrocytes are important components of BBB and
blood–cerebral spinal fluid (CSF) barrier and they respond to
GBS infection by releasing several inflammatory cytokines, which
may lead to reactive astrogliosis35,36. Therefore, inflammatory
activation of astrocytes was evaluated at PND5 using GFAP
staining in the lateral ventricles and in the hippocampus of brains
from infected pups and brains from uninfected pups. Although
the GFAP intensity was not different between the groups (Fig. 4j),
the area occupied by GFAP+ positive cells in the hippocampus
was larger in brains from infected than in brains from uninfected
pups (Fig. 4j), indicating moderate reactive-astrogliosis. The
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Fig. 3 Prenatal-GBS infection leads to brain damage in the offspring. Pregnant BALB/c mice were intra-vaginally inoculated with 3 × 104 CFU of GBS BM110
WT or PBS (uninfected) at gestational days 17 and 18. a Sections of brain tissue were prepared at PND5 and subjected to H&E staining. Representative
micrographs of individual pups infected with GBS compared with uninfected control at indicated brain regions are shown. Arrows indicate oedema, vascular
congestion and meningeal thickening in the cortex. Arrowheads depict vascular congestion and haemorrhage in the choroid plexus in the dorsal third
ventricle. Chp d3v, choroid plexus dorsal third ventricle. Scale bars are 100 μm for top and bottom, and 20 μm for middle. b Immunofluorescence detection
of GBS in the brain of an offspring born from a GBS-colonised progenitor at PND5. Scale bar, 5 μm. c BBB permeability measured by the quantitative
analysis of Evans blue leakage to the CNS at PND5. Vascular permeability of the Evans blue dye is expressed as µg of Evans blue per mg of dried
brain tissue using a standard curve. Representative fluorescence images of uninfected and infected pups’ brains analysed with the IVIS LUMINA LT are
shown. Each dot represents data from a single pup (mean, n= 4 for uninfected and BM110 WT). Comparison by unpaired Student’s t-test. *P < 0.05.
d Representative Nissl coronal sections showing cortical thickness, lateral ventricles enlargement and white matter (WM) thickness in pups infected with
GBS BM110 WT compared with uninfected controls. e These modifications were quantified in brains of uninfected and infected pups. Measures were
obtained as shown by red lines in representative sections (Image credit: Allen Institute). Scale bar, 100 μm. Each dot represents data from a single pup
(mean, n= 5 for ventricular area and WM thickness, n= 6 for cortical thickness for both uninfected and BM110 WT). Comparisons by two-way ANOVA,
with three replicate measurements per pup. **P < 0.01, ***P < 0.001
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periventricular area occupied by GFAP+ cells could not be
compared between the groups due to ventricular expansion.
To evaluate whether apoptosis contributes to the neuropathol-
ogy, neuronal apoptosis was assessed at PND5 by TUNEL
nuclei in the hippocampus, striatum, motor and parietal cortical
regions, and posteriorly at the parietal associative cortex of brains
from infected and brains from uninfected pups. As illustrated
in Fig. 4k, an increased apoptotic cell death was observed in all
assessed regions of the brains from infected pups.
Behavioural alterations in survivors of GBS meningitis. To
assess if, in our model, the offspring that survived infection with
Hoechst / TUNEL Hoechst / TUNEL
Uninfected UninfectedBM110 WT BM110 WT
St
ria
tu
m
M
ot
or
 C
x
H
ip
po
ca
m
pu
s
Pa
rie
ta
l C
x
DAPI / GFAP
Uninfected
Uninfected
BM110 WT
BM110 WT
La
te
ra
l v
e
n
tri
cl
e
H
ip
po
ca
m
pu
s
St
ria
tu
m
H
ip
po
ca
m
pu
s
DAPI / Iba1
Uninfected
Uninfected
BM110 WT
BM110 WT
Ly
6C
%
 L
y6
Ch
i
Ly6Chi Ly6Chi
CD11b
Uninfected
BM110 WT
Un
infe
cte
d
BM
11
0 W
T
Un
infe
cte
d
BM
11
0 W
T
Un
infe
cte
d
BM
11
0 W
T
Un
infe
cte
d
BM
11
0 W
T
Unstained cells
CD44
R
el
at
ive
 c
e
ll 
nu
m
be
r
R
el
at
ive
 
ce
ll 
nu
m
be
r
G
FA
P 
in
te
ns
ity
G
FA
P 
in
te
ns
ity
TU
NE
L 
po
sit
ive
 c
e
lls
/fi
el
d
TU
NE
L 
po
sit
ive
 c
e
lls
/fi
el
d
TU
NE
L 
po
sit
ive
 c
e
lls
/fi
el
d
TU
NE
L 
po
sit
ive
 c
e
lls
/fi
el
d
G
FA
P+
 
a
re
a
 (%
)
CD11b Granulocytes
Ly6G
Granulocytes
Mono/
mφs
CD11b
Infil.
Myeloid
cells
CD45
Res. Infil.
CD45
CD
45
CD
11
b
SS
C
SS
C
k
ji
hgf
edc
ba 1000
***
**
***
****
*
**
pg
 / 
m
L
m
g 
/ o
rg
an
%
 o
f t
ot
al
 b
ra
in
 im
m
u
n
e
 c
e
lls
CD
11
b 
M
FI
 (×
10
3 )
M
FI
 C
D4
4 
(×1
04
)
%
 o
f t
ot
al
 C
D4
5h
ig
h  
ce
lls
%
 o
f t
ot
al
 C
D4
5h
ig
h  
ce
lls
800
600
Uninfected
300
250
200
150
100
50
0
BM110 WT
Uninfected
BM110 WT
Uninfected
Uninfected
BM110 WT
Uninfected
BM110 WT
BM110 WT
400
200
0
250 k
200 k
150 k
100 k
50 k
0
250 k
200 k
150 k
100 k
50 k
0
–103 104 1051030 –103
–103
104 104
104
105 105
105
103
103
0 –103 104 10510300
104 1050 104 1050
0
–103
104
105
103
0
–103
104
105
103
0
–103
104
105
103
0
KC
MI
P-1
α
IL-
1β
TN
F-α IFN
-γ
IL-
6
IL-
10
IL-
17 KC
MI
P-1
α
IL-
1β
TN
F-α IFN
-γIL-
6
IL-
10
IL-
17
Resident
myeloid cells
Infiltrating
myeloid cells
Mono/mφs
(CD11b+Ly6G–)
Granulocytes
(CD11b+Ly6G+)
100 70 10
8
6
4
2
0
60
50
40
30
80
60
8
6
10 2.0 25
20
15
10
5
0
1.5
1.0
0.5
0.0
8
6
4
2
Res.myeloid
cells
0
4
2
0
50
40
30
20
10
0
50
40
30
20
10
0
50
20
15
10
40
30
20
10
0
5
0
20
15
10
15
10
5
0
5
0
*
*** ***
******
40
30
20
10
0
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05492-y
6 NATURE COMMUNICATIONS |  (2018) 9:3138 | DOI: 10.1038/s41467-018-05492-y | www.nature.com/naturecommunications
the hyper-virulent strain experienced permanent NDI, as
observed in humans, we characterised their cognitive and motor
performance in adults. The learning and memory performances
were assessed using an 8-arm radial maze task37. A significant
difference between GBS-Survivors (BM110-Survivors) and mice
born from non-colonised mother, control group (Uninfected),
was observed regarding the latency to enter to the first arm in the
first two block sessions (Fig. 5a), where the GBS-Survivors took
significantly more time to start exploring the maze. While the
Uninfected group presented a classical learning curve, with a
number of arm entries decreasing as time progressed, the GBS-
Survivors group did not alter the number of entries throughout
the test (Fig. 5b). This is further evidenced in working and
reference memory performances, for which GBS-Survivors pre-
sent higher relative error rates at the final sessions, indicating a
diminished ability to learn the task (Fig. 5c, d). General motor
function and exploratory behaviour were assessed in the open
field test (OFT). GBS-Survivors display a significant decrease in
the total distance travelled in the OFT (Fig. 5e). Importantly, both
the number of crosses between the peripheral and central area
and the time spent in the central area were significantly reduced
for the GBS-Survivors group (Fig. 5f, g), which is a sign of
anxious-like behaviour. When analysing the exploratory activity
of GBS-Survivors, data revealed that these animals present a
significantly lower frequency and time spent in investigatory
behaviours such as rearing and exploration, when compared to
controls (Fig. 5h, i). These animals also showed an increase of
immobility time and frequency (Fig. 5h, i). Globally these results
show that GBS-Survivors presented compromised activity and
exploration abilities, as well as anxiety-related behaviours.
GBS meningitis leads to an altered neurotransmitter pattern.
To understand if the observed learning and behaviour changes in
GBS-Survivors mice are related to the levels of relevant neuro-
transmitters (dopamine and metabolites, norepinephrine, gluta-
mate, and GABA), these molecules were quantified in brain
regions involved in memory acquisition, learning and motor
activity by HPLC-ED.
In the hippocampus, a major glutamatergic region that receives
relevant dopaminergic input, we observed significantly reduced
levels of glutamate, dopamine and its metabolite DOPAC for the
GBS-Survivors (BM110-Survivors) (Fig. 5j, k). In the striatum, a
predominantly GABAergic region modulated by nigral dopami-
nergic inputs and cortical glutamatergic projections, we observed
reduced levels of dopamine metabolites (DOPAC and HVA) for
the GBS-Survivors group (Fig. 5l), which are indicative of
decreased dopaminergic turnover. Altered dopaminergic activity
in this region is associated with thalamic deregulation of
glutamate release38. Accordingly, we observed in the thalamus a
significant reduction of glutamate levels for the GBS-Survivors
group (Fig. 5m), which is also consistent with a decreased activity.
No other differences were observed in the levels of dopamine,
norepinephrine, glutamate or GABA in any of the evaluated brain
regions (hippocampus, striatum, prefrontal cortex, amygdala, and
cerebellum) (see Supplementary Tables 1 and 2).
Globally, mice born from BM110-colonised mothers present a
meaningful number of alterations in learning ability as well as in
the spontaneous behaviour, which is in agreement with the
observed decreases in glutamatergic and dopaminergic functions
in the hippocampus and the striatal-thalamic circuit.
Discussion
We here describe a novel mouse model that reproduces all steps
of GBS infection in humans. Transmission of this bacterium from
mother to the neonate results either from ascending spread of
bacteria or, alternatively, through ingestion or aspiration of
contaminated vaginal fluids during delivery2. Maternal vaginal
colonisation is thus the critical initial step of this invasive neo-
natal disease. To validate this model, we used the GBS strain
BM110 belonging to the hypervirulent lineage CC17 responsible
for approximately 80% of meningitis cases due to GBS in neo-
nates and the attenuated mutant derivative BM110ΔcylE not
expressing the β-hemolysin/cytolysin. BM110 efficiently colo-
nised the vaginal mucosa of pregnant females and a transient and
intermittent vaginal colonisation was observed after delivery, as
observed in humans39. Most importantly, the hypervirulent strain
colonises the vagina of pregnant mice more efficiently than the
attenuated strain. These results confirm previews studies showing
that β-hemolysin/cytolysin expression is involved in adherence of
GBS to the murine vaginal tract of nonpregnant mice following
treatment with 17β-estradiol40,41.
In human neonates, the lung is the primary organ infected by
GBS upon vaginal fluids aspiration, with one-third to more than
half of infants showing lung symptoms within hours after birth2.
In our murine model, 60% of pups infected with the hyper-
virulent GBS strain that survived (a percentage similar to that
reported in humans before IAP introduction) presented respira-
tory pathology. In addition, these pups had elevated GBS levels in
their lungs later in life, which is consistent with previous studies
reporting that throat and rectal cultures are the best sites for GBS
Fig. 4 Prenatal-GBS infection induces microglia activation and neuronal apoptosis in the offspring. Pregnant BALB/c mice were intra-vaginally
inoculated with 3 × 104 CFU of GBS BM110 WT or PBS (uninfected) at gestational days 17 and 18. Analyses were performed at PND5. a, b Levels of serum
(a) and brain (b) cytokines were quantified. Each dot represents data from one pup (mean, n= 6). Comparison by unpaired Student’s t-test. **P < 0.01,
***P < 0.001. c Representative flow cytometry plot scheme showing gating strategy. SSC: side scatter, Res: resident, Infil: infiltrating, Mono: monocytes,
mϕs: macrophages. d, e Quantification of CD45low/intCD11b+ (resident myeloid cells), CD45highCD11b+ (infiltrating myeloid cells), CD11b+Ly6G− (Mono/
mϕs) and CD11b+Ly6G+ (Granulocytes) populations [mean, n= 4 (uninfected) and n= 5 (BM110 WT)]. Comparison by unpaired Student’s t-test.
*P < 0.05. f, g Quantification of CD11b on microglia (f) and CD44 on granulocytes (g), presented as median fluorescence intensity (MFI). Representative
histograms are shown. Black line, pups infected with BM110 WT; dotted line, uninfected pups; grey line, unstained cells. Mean, n= 4 (uninfected) and n= 5
(BM110 WT). Comparison by unpaired Student’s t-test. *P < 0.05, ***P < 0.001. h Quantification of Ly6Chi on infiltrating Mono/mϕs with representative
dotplots [mean, n= 4 (uninfected) and n= 5 (BM110 WT)]. Comparison by unpaired Student’s t-test. **P < 0.01. i Representative images of striatal and
hippocampal microglia stained with Iba1. Arrows indicate relevant morphologies, as depicted in lateral panels of isolated cells. Nuclei were stained with
DAPI. Scale bar, 50 µm. j GFAP-stained astrocytes in representative coronal sections of the lateral ventricles and hippocampus (CA3). GFAP intensity
and area were quantified to evaluate astrocytes reactivity. Nuclei were stained with DAPI. Scale bar, 50 µm. Each dot represents data from a single pup
(mean, n= 3 for uninfected and BM110 WT). Comparisons by two-way ANOVA with repeated measures. *P < 0.05. k Quantification and representative
coronal sections, processed for TUNEL assay, of motor and associative cortical regions, striatum and hippocampus (CA3). Nuclei were stained with
Hoechst. The arrow indicates TUNEL-positive nuclei showing DNA fragmentation and apoptosis. Scale bar, 50 µm. Each dot represents data from a single
pup (mean, n= 4). Comparisons by two-way ANOVA with repeated measures. ***P < 0.001
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detection in childhood42,43. As expected, pups infected with the
β-h/c toxin-deficient strain had low levels of systemic colonisa-
tion. However, both strains were detected in the gut during the
neonatal period and adulthood in animals, revealing that GBS-
commensalism is likely established during early life, without the
contribution of β-h/c. These data support the hypothesis that the
gastrointestinal tract is the GBS reservoir and the most likely
source of vaginal colonisation in humans44,45. Whether this form
of commensalism is a cause of transition to invasive niches
remains unknown. As reported in an adult murine model of
haematogenous GBS meningitis25, bacteria were found in the
brains of neonatal mice infected with the WT or the β-h/c-defi-
cient mutant strain, albeit at lower levels with the mutant strain.
Consistently, screening of a large collection of human GBS iso-
lates led to the suggestion that β-h/c production contributes to,
but is not essential for virulence, as non-haemolytic isolates were
found in strains originating from invasive diseases including
CC17 strains46. Therefore, more exploration is needed to
understand the role of non-hypervirulent GBS infections in brain
damage and behavioural sequelae.
Previous mouse models of intra-vaginal infection during
pregnancy have also been described26,47. However, to follow
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Fig. 5 GBS-Survivors mice present behavioural sequelae and altered glutamatergic and dopaminergic function, in adulthood. Pregnant BALB/c mice were
intra-vaginally inoculated with 3 × 104 CFU of GBS BM110 WT or with PBS (uninfected) at gestational days 17 and 18. Offspring that survived to infection
(BM110 WT-survivors) and mice born from non GBS-colonised mothers (uninfected) were examined at PND90 for their capacity to execute tasks in the
radial arm maze (a–d) and tested in an open field (OF) test (e–i). a–d Latency (a), total number of arms entries (b), working memory errors (c) and
reference memory errors (d) in the radial arm maze test. e-i Total distance travelled in centimetres (e). Frequency (f) and time spent in the periphery and
centre of OF apparatus (g). Frequency (h) and time of exploratory behaviour (i). Data are presented as means ± SEM, or individually (n= 6 for uninfected
and BM110 WT-survivors). Comparisons by two-way ANOVA, with repeated measures for block sessions or unpaired Student’s t-test for the other
evaluations. *P < 0.05, **P < 0.01, ***P < 0.001. i-m Levels of Glutamate in the hippocampus (j) and thalamus (m), and DA and metabolites (DOPAC and
HVA) in the hippocampus (k) and striatum (l) of offsprings that survived to neonatal GBS infection (BM110WT-survivors) or born from non GBS-colonised
mothers (uninfected), were determined by HPLC-EC at PND90. HVA levels in the hippocampus were below the detection limit. Relative levels are shown
and normalised to total protein content. Each dot represents data from a single animal (mean, n= 6 for uninfected and BM110 WT-survivors). Comparison
by unpaired Student’s t-test. *P < 0.05, ***P < 0.001
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ascending GBS infection to the foetus and preterm birth, a pro-
tocol with a high bacterial inoculum was used, leading to infec-
tion and severe intrauterine foetal demise with significant
maternal bacteraemia26,47. Our model is different because new-
borns acquire the bacterium during delivery mainly by ingestion
or aspiration of vaginal secretions colonised by GBS, which allows
substantial neonatal survival and thus the study of meningitis
pathophysiology. Moreover, we confirmed that pregnant females
inoculated with a hypervirulent mutant strain CC17 lacking β-h/c
showed a decrease in vaginal colonisation and vertical transmis-
sion to offspring, as compared to the haemolytic parental strain26.
A minimum bacteraemia threshold is considered required for
meningeal invasion48. However, we show that at PND1, 40% of
infected animals had bacteraemia below the detection threshold,
and this percentage decreases to 25% at PND5 although ~94% of
pups had bacteria in their brain. This observation is very
important as human blood cultures are negative in 15–38% of
cases12. It should be noted that 50% of pups infected with the
mutant strain β-h/c also had GBS in their brain with no bacteria
detected in the blood. Thus, our model summarises the patho-
genesis of human GBS infection and is able to discriminate the
effects of the hyper-virulent strain and an attenuated mutant
derivative. Hence, it is different from a model of GBS-induced
maternal infection leading to a deleterious neurodevelopmental
impact on uninfected offsprings, and which does not discriminate
between inactivated and live GBS49. However, our model does not
allow the study of premature births and foetal deaths caused by
GBS and, because of the size of the animal, the collection of CSF
samples. Moreover, it does not clearly distinguish between the
early-onset and late-onset diseases. Lastly, it does not allow
investigating the possible transmission of GBS via infected breast
milk50 or hematogenous and peritoneal routes51.
Although meningitis is classically defined as an inflammatory
disease of the meninges, it is not limited to these membranes, and
adverse consequences on brain dysfunction seem to be, at least
partially, associated with the host neuroinflammatory response52.
Glia activation is one of the first hallmarks of neuroinflamma-
tion53, but the specific contribution of different cell types to brain
inflammation and cell death in GBS-induced meningitis remains
unknown. The initial inflammatory response is thought to
depend on activation of innate immune receptors54. Direct RNA
sequencing analysis demonstrated that microglia express high
levels of several sensome genes, including the Toll-like receptor 2
(TLR2)55 and this receptor is up-regulated in the neonatal brain
under physiological conditions56. Moreover, TLR2-signalling
might has detrimental effects in the immature brain54, and dur-
ing neonatal sepsis57. Peripheral administration of the TLR2
ligand Pam3CSK4 to neonatal mice induced a dramatic accu-
mulation of neutrophils and monocytes in the CSF, indicating
that systemic activation of TLR2 leads to an increased inflam-
matory response in the brain58. Here, we did not observe the
recruitment of leucocytes into the brain at a time when systemic
infection persists. The absence of neutrophil infiltration was also
reported in a neonatal stroke model59. However, we observed a
decrease in the proportion of Ly6G-Ly6Chi monocytes and a
smaller increase in Ly6G-Ly6Cint/low monocytes in the brains of
infected pups. Ly6Chi monocytes deficiency has been associated
with altered hippocampal neurogenesis32 and Ly6G-Ly6Cin/low
monocytes have recently been associated with impaired motor
learning and dendritic spinal plasticity related to learning60.
Microglia undergoes rapid activation and proliferation upon
brain injury. Accordingly, we found increased microglia activa-
tion and a morphology shift towards a reactive phenotype33 that
was particularly evident in the dorsal striatum, near the lateral
ventricles in infected brains where apoptosis was also more
expressive.
Apoptosis and reactive astrogliosis, another hallmark of neu-
roinflammation, were observed in the hippocampus of infected
pups. This brain region is frequently associated with cognitive
neuronal sequelae induced by GBS meningitis61. Expansion of
the lateral ventricles was also observed in the brain of infected
pups. This is a likely consequence of the on-going ventricular
neuroinflammation that may evolve to ventriculitis and hydro-
cephalus, two possible complications of GBS-induced meningi-
tis29. It should be noted that the cortical thinning observed in the
brains of infected pups, likely resulting from an expansion of
lateral ventricles29, may impair cognitive function at later stages.
We observed a lower concentration of some inflammatory cyto-
kines in the serum of infected pups that could be explained by the
unique features of the neonatal immune system highly regulated
by multiple factors62.
No differences were observed for the levels of inflammatory
cytokines in the brain of infected or uninfected pups. Thus, brain
damage is unlikely due to local or systemic inflammatory cyto-
kines. Moreover, it is also unlikely that brain cells are directly
damaged by bacteria, as apoptosis was observed in several regions
with no detectable GBS. Therefore, neurotoxicity molecules such
as reactive oxygen species, nitric oxide, peroxynitrite, metallo-
proteinases, and excitatory amino acids, can be the responsible
for neuronal injury associated with GBS meningitis63,64. Alto-
gether, these data support the hypothesis that local, rather than
systemic inflammation, contributes to NDI in GBS meningitis.
Though data are scarce concerning permanent NDI in sur-
viving neonates, a study showed that, despite reduced mortality
(5.5%), long-term outcomes of GBS meningitis were remarkably
similar to a report from 19859,11. These studies showed that
among the survivors of an initial episode of GBS meningitis, one-
half presented global or mild-to-moderate mental retardation,
including learning disabilities, and language deficits, with asso-
ciated neurologic abnormalities. More recently, a systematic lit-
erature review and meta-analysis for NDI outcomes due to GBS
meningitis showed that almost one-fifth of survivors presented
moderate to severe NDI10. It is likely that this value is under-
estimated due to limited data from low and middle-income
populations, which accounts for more than 90% of the world’s
births and where health care systems are often poorly devel-
oped10. In our experimental model, the GBS-Survivors mice
presented reduced exploratory activity in adulthood as well as
impairment in learning and memory as evaluated in the radial
maze. The reduced activity observed did not seem to affect the
learning process since the number of increased errors observed in
GBS-Survivors performance is not globally a reflex of reduced
arms entries. Altered neurotransmitter patterns in several brain
regions further sustained these differences. Glutamate, that plays
a crucial role in learning and memory formation65, was decreased
in the hippocampus of GBS-Survivors mice and could reflect the
learning and memory disabilities found in children that survive
meningitis66. The dopaminergic system is usually associated with
the control of movement and decision making67,68. Dopaminer-
gic inputs into the hippocampus and the frontal cortex are also
relevant to learning and attention67. In our model, the levels of
DA and its metabolite DOPAC were significantly decreased in the
hippocampus from GBS-Survivors, justifying the impairments
observed. The basal ganglia are involved in reward-based learning
and motor function68. The major site of synaptic plasticity in the
basal ganglia is the striatum, which receives cortical glutamatergic
inputs and dense dopaminergic projections69. Mice that survived
to neonatal GBS infection displayed reduced DA metabolism in
the striatum, which is in agreement with reduced global activity,
and a likely consequence of the postnatal inflammatory response
described above. Of note, this can lead to decreased influx of
glutamate from the thalamus to the motor cortex and result in
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hypokinesia70. In accordance, we detected significantly lower
glutamate levels in the thalamus from GBS-survivor animals,
which may also impact on other areas of the neocortex, since
glutamatergic afferents from the thalamic region serve as a
cortex relay71.
Our experimental model closely mimics the human GBS
infection during birth and is the first that enables a mother-to-
child transmission leading to GBS-induced diseases (Fig. 6).
It constitutes a useful tool to study the pathophysiological
mechanisms of CNS inflammatory response during GBS
meningitis, as well as to study how bacteria circumvent the
blood–CNS barriers, aiming at reducing neurological and neu-
ropsychiatric morbidities in maturing newborns.
Methods
Bacterial strains and growth conditions. GBS strain BM110 (here referred to as
BM110 WT), a capsular serotype III strain belonging to the hyper-virulent clonal
complex 17 (CC17), is a well-characterised isolate from humans with invasive
infections72. The isogenic non-haemolytic (βH/C-deficient) ΔcylE mutant (here
referred to as BM110ΔcylE) was constructed by deleting in-frame the gene cylE
as previously described73. GBS BM110 WT and the ΔcylE mutant were cultured at
37 °C in Todd-Hewitt broth or agar (Difco Laboratories) containing 5 µg/mL of
colistin sulphate and 0.5 μg/mL of oxalinic acid (Streptococcus Selective Supple-
ment, Oxoid).
Animals and ethics statement. Six- to eight-week-old male and female BALB/c
mice were purchased from Charles River. All animals were kept at the ICBAS
animal facilities during the time of the experiments. All experiments were con-
ducted in strict accordance with the recommendations of the European Convention
for the Protection of Vertebrate Animals used for Experimental and Other Sci-
entific Purposes (ETS 123) and Directive 2010/63/EU and Portuguese rules (DL
113/2013). All experimental protocols including animals were approved by the
competent national authority Direcção Geral de Alimentação e Veterinária
(DGAV), and by the ICBAS Animal Ethical Committee (No 113/2015). People
directly involved in animal experiments were also certified by DGAV. All efforts
were made to minimise animal suffering and to reduce the number of animals
used. No animals were excluded from the analysis. Since our experiments were
designed to colonise progenitors during pregnancy, we did not randomise their
litters. No blinding was carried out.
Gestation time and pregnancy monitoring. Since the presence of vaginal plug is
not a definitive indicator of true pregnancy, particularly in inbred mice74 body
weight was used jointly to determine the time of gestation. Two to three females
were housed with one male and examined daily for the presence of vaginal plug at
the beginning of the light cycle. When the vaginal plug was observed, the female
was separated and housed individually until delivery. Nest material was provided to
each dam and no bedding changes were performed during the last days of preg-
nancy. The day of the vaginal plug detection was considered as gestation (G) day
one (G1) and the day of delivery designated as postnatal day (PND) 0. All animals
were accustomed to the investigator, in order to reduce stress. Pregnant BALB/c
mice were intra-vaginally (i.vag.) inoculated at G17 and G18.
Neonatal mouse model of GBS meningitis. Overnight GBS cultures were sub-
cultured 1:100, grown until mid-log phase (OD600 ~0.800), pellet and washed twice
with sterile phosphate-buffered saline (PBS). Pregnant BALB/c mice were i.vag.
inoculated with 40 µL containing 3 × 104 GBS cells using a micropipette. This
period of intervention to bacterial administration has been determined to be the
optimal, as early administration did not allow pregnancy to reach term (data not
shown). Pregnant females were allowed to deliver by spontaneous partum that
occurred at G20-G21 and infected pups were kept with their mothers during the
first 30 days after birth. When indicated, a group of females received ampicillin
(Sigma) in their drinking water (1 mg/mL), from 1 day prior to delivery (G20) until
1 day after birth. Vaginal lavages were collected by vaginally instilling 50 μL of
sterile PBS with a micropipette and repeatedly (10 times) removing and introdu-
cing the PBS. This was repeated twice and 150 µL of vaginal lavage were recovered
at the indicated time points. Vaginal lavages were serially diluted, plated on
selective medium (CHROMagar StrepB agar) and incubated overnight at 37 °C.
The litter size and pup weight were assessed during the first 10 days after birth.
Survival curves were determined in a 30-day period monitored every day. To assess
bacterial colonisation, the liver, lungs, gut and brain were aseptically removed at
the indicated PND and homogenised in PBS. Serial dilutions were prepared in
sterile saline, and plated for CFU counts. Blood was collected by decapitation to
avoid extreme hypovolaemia associated with stress and pain. Samples were col-
lected in heparinized containers and plated for CFU counts. At the indicated time
points, gut was collected and recovered GBS were enumerated by light pink or
mauve colonies on CHROMagar StrepB agar.
Blood–brain barrier permeability to Evan’s blue. The blood–brain barrier
integrity was investigated using Evan’s blue dye extravasation. At PND5 neonatal
mice were intraperitoneally injected with a 2% solution of Evans Blue in PBS (4 µl/g
of body weight). Three hours (h) later, animals were deeply anaesthetised and
perfused with saline. The whole brain was removed and wrapped in aluminium
foil. The organs were dried for 48 h in an oven at 55 °C and Evans Blue was
extracted by addition of formamide (8 µl / mg brain). After an additional 48 h
period at 55 °C, Evans Blue stain was measured by spectrophotometer at 620 nm
and quantified according to a standard curve. The results were presented as µg of
Evans Blue per mg of dried tissue. To visualise the fluorescence of Evans blue
brains were following perfusion and fixation with paraformaldehyde (PFA),
acquired with an IVIS Lumina LT (Perkin Elmer). The detection of the fluorescent
signal by the system resulted in the generation of signal maps automatically
superimposed to the grey-scale photograph of the brain using the Living Image
software (Perkin Elmer).
Blood biomarkers of organ injury. Serum samples from moribund BM110 WT-
infected animals, or uninfected controls were collected at PND1. The following
biochemical parameters were measured in the serum as markers of multiple organ
failure: liver injury was assessed by measuring serum concentrations of aspartate
transaminase (AST); kidney dysfunction was evaluated by measuring the increase
in creatinine and blood urea nitrogen (BUN); and cardiac lesions were assessed by
measuring creatine kinase (CK). The determinations were made using a com-
mercial kit (Idexx laboratories).
Histopathology examination and immunohistochemistry. For histopathology
examination, brain and lungs were removed at the indicated time-points, fixed in
4% buffered formalin, routinely processed, and embedded in paraffin. Histologic
4–5 µm-thick sections were cut for staining or immune detection. Hematoxylin and
eosin (H&E) staining were performed according to per standard protocols. H&E-
stained sections were analysed by a pathologist (A.F.). Slides were assigned random
numbers that had no relevance to the experiment for a blind analysis.
For immunohistochemistry analysis, animals were deeply anaesthetised,
perfused with PBS, followed by 4% PFA in PBS. The brains were removed, post
fixed by immersion in 4% PFA for 48 h, at 4 °C, washed with PBS and then
cryoprotected using sucrose 30%. Samples were thereafter mounted in OCT
(Thermo Scientific) embedding medium, frozen and cryosectioned in the CM3050S
Cryostat (Leica Biosystems). Brain coronal sections (30 μm) were collected in
Superfrost ultra plus slides (Thermo Scientific), and stored at −20 °C until
Mouse model of GBS pathogenesis
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Fig. 6 Neonatal mouse model of GBS pathogenesis. GBS colonises the
vaginal tract of pregnant mice. The newborn acquires the bacteria during
birth, causing pneumonia, septicaemia, and meningitis. Scientific illustration
by Gil Ferreira da Silva
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processed. Immunohistochemistry analysis was performed as previously described,
with slight modifications75. Briefly, glass slides containing frozen sections were
defrost at least 2 h and then hydrated with PBS for 15 min. Sections were fixated
with 4% PFA, washed three times, permeabilized with 0.25% Triton X-100 for 10
min and washed with PBS for 5 min. Sections were then blocked (5% BSA, 5% FBS,
0.1% Triton X-100) for 1 h and primary antibodies were incubated overnight in
blocking solution in a humidified chamber overnight at 4 °C. The following
antibodies were used: 1:500 anti-Iba-1 (Wako), 1:500 anti-GFAP (Abcam), 1:200
anti-Streptococcus Group B antibody (Abcam). Next, sections were washed three
times for 10 min with PBS and relevant secondary antibodies [1:1000 Anti-Rabbit
Alexa 488 (Cell Signalling Technology), 1:1000 Anti-Rabbit Alexa 594 (Thermo
Fisher Scientific) and 1:400 Anti-Rabbit Alexa 568 (Thermo Fisher Scientific)] were
incubated for 2 h in blocking solution. For nuclei visualisation, sections were
washed three times for 10 min with PBS and incubated for 10 min with Hoechst or
4,6-diamidino-2-phenylindole (DAPI). The apoptosis was measured by TUNEL
assay following instructions provided by the manufacturer (Promega). Slides were
cover slipped using Fluoroshield (Sigma) and visualised under a Zeiss Axio Imager
Z1 microscope. To assess cytoarchitecture sections were dipped in Cresyl Violet
solution (0.5% cresyl violet in 0.3% acetic acid), rapidly dehydrated and mounted
with DPX (BDH).
Image analysis and quantification. For each animal, 3 images per region were
obtained by selecting brain sections that where within Bregma 0.4 to 0.6 (striatal
region) and −3.80 to −4.30 (hippocampus) as illustrated in Fig. 3e. Images were
acquired using uniform settings and exported preserving original metadata. For
Iba1 and GFAP images, fluorescence channels were separated, images converted to
32-bit and the background subtracted using 50%-off pixels radius by the rollerball
algorithm. The amount of Iba1 positive pixels per total area was considered. For
GFAP, deconvolved images were segmented in FIJI using an automatic local Otsu
threshold algorithm (based sole on the maximum intensity in the distribution
histogram). Mean grey values for the intensity and total area of GFAP expression
were returned for each image using the measure function on Image J (version 1.50i
for Mac). TUNEL positive cell were count manually using also 3 replicates per
region and subject. Individual values for each image were exported to the Prism
software (Prism 7 for Mac OS X) for statistical analysis.
Flow cytometry of leucocytes in the brain on neonatal mice. For flow cytometry
of brain tissue, pups at PND5 were deeply anaesthetised, perfused with saline, and
euthanized by decapitation. Brains were excised, gently dissociated and cells were
passed through a 100 µm cell strainer. Stock isotonic Percoll (GE Healthcare) (SIP)
90% (in HBSS without Ca2+ and Mg2+) was added to each cell suspension to
obtain a final 30% SIP. Slowly the cell suspension was added on top of the 70% SIP
avoiding mixing of the 70 and 30% solutions. Percoll gradients were centrifuged
(500g, 30 min, at 22 ˚C) and the enriched population of leucocytes/microglia was
collected at the 70–30% interphase. After isolation, cells were washed and counted
in a CountessTM Automated Cell Counter (Thermo Fisher Scientific). Thereafter,
5 × 105 cells were incubated with Ly6G FITC (Clone 1A8), CD45 PE (Clone 30-
F11), Ly6C PerCP/Cy5.5 (Clone HK1.4), CD11b PE/Cy7 (Clone M1/70), MHC-II
BV421 (Clone M5/114.15.2), and CD44 BV510 (Clone IM7), all from Biolegend,
diluted in FACS staining buffer (2% BSA, 0,1% sodium azide in PBS). Data were
acquired in a FACSCanto II flow cytometer (BD Biosciences). Post-acquisition
analysis was performed using FlowJo software v10 (Tree Star). Gating strategy is
shown in Fig. 4.
Multiplex cytokine assay. Serum samples were collected at PND5. For brain
analysis, animals were deeply anaesthetised and perfused with saline. Brain tissue
samples were frozen on dry ice immediately upon removal. Brains were homo-
genised on ice in RIPA buffer (Sigma-Aldrich) containing protease inhibitor
cocktail (Roche). The ground tissue was frozen at −80 °C and thawed to improve
cell lysis. Lysates were pelleted by centrifugation (4500g, 4 min, 4 °C) and super-
natants stored at −80 °C until use. Cytokine assay was performed by using a Bio-
Plex custom 8-Plex kit (Bio-Rad) following the manufacturer protocol, and a
Luminex MAGPIX Instrument. Serum samples were diluted 1:4 in diluent buffer,
and brain suspensions were diluted 1:2 to load approximately 1 mg of protein.
Detection limits were as follows: KC, 3.08 pg mL−1; MIP-1α, 1.26 pg mL−1; IL-1β,
1.14 pg mL−1; IL-6, 1.36 pg mL−1; TNF-α, 6.36 pg mL−1; IL-17, 1.1 pg mL−1;
IFN-γ, 1.96 pg mL−1; IL-10, 9.24 pg mL−1. Data from brain were normalised
relative to protein concentration.
Behavioural assessments. The behavioural tests were performed in a sound
attenuated, temperature (21 ± 1 °C) and humidity (70%) controlled room with a
12-h-light–dark cycle (lights at 7 a.m.), using male animals at PND90 (mature
adults), from different litters. Females were not used due to concerns about hor-
mones fluctuation associated with oestrous cycle, which produce greater variability
in behavioural data76. In the radial maze test animals were kept at approximately
90% (26.64 ± 1.28 g) of their free feeding body weight and began training after
reaching this weight. Since food restriction is required to induce motivation to
search for food (pellet reward), during the whole test period mice had restricted
access to food (only fed following testing). Their weight and general health were
carefully monitored every day to prevent more than a 10% body weight loss.
Radial maze test: The cognitive status of the animals as regards spatial learning
and memory was assessed with the 8-arm radial maze. Working and reference
memory were assessed simultaneously through a fixed position reward task, in
which half of the arms were baited and their positions were fixed throughout the
training trails. The radial maze consists in a central area (22 cm in diameter)
giving access to eight equally-sized arms in transparent acrylic (length, 25 cm;
width, 6.5 cm). Identical food wells (2.5 cm deep and 3 cm in diameter) were placed
at the distal end of each arm. Commercialised sugar pellets (Bioserv F0042 - DPP’S
45MG SUGAR 50TH) located at the end of each baited arm were used as rewards.
Two days prior to the beginning of the test, the rewards were placed once a day in
the animal cages, to allow them to explore and eat the pellets. There were extra-
maze clues including free-standing laboratory equipment, and geometric pictures
in walls to help mice navigation. A digital stopwatch was used to record the
amount of time taken to a mouse to complete a trial.
Habituation/training: On the first habituation day, each animal was placed
alone in the centre of the starting platform and allowed to freely explore the maze.
On the second habituation day, the mice were allowed to explore the apparatus
with randomly placed food pellets throughout the maze, for a 5 min period. On the
third habituation day, the food pellets were placed at the distal end of each arm and
the animals were allowed to explore for 5 min. The habituation period ended after
the mouse ate at least 4 rewards or when 5 min had elapsed whichever came first.
Test: During the test phase, 4 out of 8 arms were baited and randomly assigned
for each mouse, but always constant for the same animal throughout the trial
period, and the mice were given a maximum of 5 min to complete the maze.
Geometrical figures placed on the walls and the researcher were the only visual
extra maze cues present. In each training session, the mouse was placed within a
transparent cylinder on the platform in the middle of the maze for few seconds.
The cylinder was then lifted and the animal was allowed to move freely in the maze.
It was considered that an animal had entered an arm when the 4 paws and the tail
were inside it. Trials ended when the animal had either eaten all 4 rewards or 5 min
had passed, whichever came first. Once the animal returned to the central platform
and the cylinder was lowered, a minute later the next trial took place. One session
of two trials was performed per day over 14 days. The maze was rotated and wiped
with a dextran solution at 2% between animals to eliminate or reduce olfactory cues
from different individuals.
Behavioural analysis: There were 4 measures used in behavioural analysis. The
number of errors made: working memory error, defined as re-entering an arm
already visited within a trial; and a reference memory error, defined as entering a
never baited arm. Trial completion time was also included. It started when the
cylinder was lifted, in which the mouse had full access to explore the maze, and
stopped when the animal entered the fourth baited arm. Response latency was also
measured and defined by the total session duration divided by the number of arms
entered (seconds per entry). Seven blocks were calculated by average measure of
four trials per day.
Open field (OF): Exploratory behaviour and general locomotor function were
assessed in the open field test. The apparatus consisted of a brightly illuminated
open-field square arena (40 × 40 × 40 cm). The OF arena is virtually divided into
16 equal squares, via a 4 × 4 grid to assist with data analysis. In each session, mice
were individually placed in the centre of the arena and allowed to freely explore it
for 5 min. All trials were recorded by a video camera (SONY DCR-SF 290),
suspended above the test arena, and analysed afterwards using the software package
Observer XT 7.0 (Noldus Information Technology). The following parameters were
assessed: total distance walked, frequency and time spent in centre or periphery
section of the OF. The number of rears (i.e. mice reared on its hind paws, both on
or off the walls), arena exploration and time spent unmoved were also scored. The
apparatus was cleaned between subjects with a solution of 2% dextran.
Neurotransmitter determination. After the completion of behavioural studies,
mice were euthanized by decapitation and the brains rapidly microdissected on ice
and quickly frozen at −80 °C. Amino acid levels and the levels of monoamines and
their metabolites were measured by high performance liquid chromatography,
combined with electrochemical detection (HPLC/EC), using a Gilson instrument
(Gilson, Inc., Middleton, WI, USA), as previously described77.
Amino acids quantification: For gamma-aminobutyric acid (GABA) and
glutamate evaluation, the prefrontal cortex, hippocampus, striatum and cerebellum
were used. The day before the neurochemical determination, tissues were thawed,
and homogenised in 200 µL of ice-cold 150 mM potassium buffer with phosphoric
acid, through ultrasonication (Sonifier W-250, Branson Ultrasonics) and
centrifuged at 16,000g, for 10 min at 4 °C. The supernatant was collected, diluted
1:2 in dilution solution (0.4 N perchloric acid, 0.4 mM sodiumm dissulfite, 0.9 mM
EDTA), filtered thought a 0.2 µm nylon microfilter (Corning) at 16,100g for 5 min,
at 4 °C, and stored at −20 °C overnight. Afterwards, samples were derivatized by
adding 100 μl of NaOH 0.1 N and 15 μl OPA (10 mgmL−1 of o-phthaldialdehyde
(OPA), 45.4 M sodium sulphite, 4.5% absolute ethanol in 327 mM borate buffer at
pH 10.4) to 50 μL of sample. Samples were allowed to react at room temperature in
the dark, for 10 min and then injected into the HPLC system. The mobile phase
consisted of 0.06 M sodium dihydrogen phosphate, 0.06 mM EDTA and 20%
methanol, pH adjusted to 4.4 with phosphoric acid and it was filtered and degassed.
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The flow was maintained at 0.8 mLmin−1. Concentrations of GABA and glutamate
were calculated using a standard curve generated with a glutamate and GABA
standard (Sigma-Aldrich). Final results were expressed in terms of amino acid
content per total amount of protein.
Monoamines and their metabolites quantification: Levels of norepinephrine
(NE), dopamine (DA), 3,4-diydroxyphenylacetic acid (DOPAC) and homovanillic
acid (HVA) were determined in the striatum, prefrontal cortex, hippocampus
and amygdala. The different brain regions were ultrasonicated in 200 µL of ice-
cold 0.2 M perchloric acid and centrifuged at 13,000g for 3 min at 4 °C. The
supernatant was then collected and filtered as described above. Aliquots of 120 µL
were injected into the HPLC system, using a mobile phase of 70 mM of potassium
phosphate monobasic buffer (pH adjusted to 3.0 by adding phosphoric acid) in
10% (v/v) of methanol, 1 mM 1-heptanosulfonic acid and 107.5 mM Na-EDTA.
The flow was maintained at 0.8 mLmin−1. Concentrations of neurotransmitters
were calculated using standard curves generated with standard monoamines
(Sigma). Final results were expressed in terms of monoamine content per total
amount of protein.
Total protein determination. Protein content was determined using the BCA
Protein Assay Kit (Thermo Scientific-Pierce). Briefly, bovine serum albumin (BSA)
was used as a standard protein (0.01–0.5 mgmL−1). 10 µL of sample or BSA
standard in duplicate were loaded into a microplate and added 200 µL of working
reagent to each well. After 30 min incubation at 37 °C, absorbance was read at
562 nm using a microplate reader.
Statistical analysis. All data were analysed with the GraphPad Prism software
(v.7, GraphPad software Inc. CA). Means and standard errors of the means (SEM)
were calculated and correspond to the indicated independent experiments. The log-
rank (Mantel–Cox) test was used to analyse the survival curve. The data from
radial maze test were submitted to analyses of variance (ANOVA) with repeated
measures for block sessions. Each block-session was calculated by average measure
on two successive trials. Differences between multiple groups were analysed by
one-way or two-way ANOVA, whenever appropriate, with the Sidak’s Multiple
Comparison Test, for α= 0.05. Image analysis was made using two-way ANOVA
with repeated measures. All other comparisons were done with an unpaired
student’s t test. Normality was verified by the Shapiro–Wilk normality test.
Homogeneity of variance was estimated by an F test. Assumptions of sphericity in
ANOVA were also verified. The minimum sample size was determined using
G*Power analysis for two-tail t-test comparing the mean and standard deviation of
two independent groups with effect size d= 7, α= 0.05 and power of 0.95. CFU
data were log10 transformed. Significance was represented by the following sym-
bols: *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, and n.s. not significant.
Data availability. All relevant data supporting the findings of the study are
available in this article and its Supplementary Information files, or from the
corresponding author upon request.
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